Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2019
2019 World Conference on Lung Cancer
Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2848
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
JCSE01 - Joint IASLC-CSCO-CAALC Session
- Type: Joint IASLC-CSCO-CAALC Session
- Track:
- Presentations: 0
- Moderators:Chunxue Bai
- Coordinates: 9/07/2019, 07:00 - 11:15, Toronto (1985)
-
+
JCSE01.26 - PD-1 Inhibitor Plus Chemotherapy as 2nd/Subsequent Line Setting Demonstrate Superior Efficacy over PD-1 Inhibitor Alone in Pts of Advanced NSCLC
10:45 - 10:45 | Presenter: Shengxiang Ren
- Abstract
Loading...
-
+
EP1.04 - Immuno-oncology
- Type: E-Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall
-
+
EP1.04-40 - Extra-Thoracic Metastasis Indicated Worse Clinical Efficacy on Immune Checkpoint Inhibitors in Chinese Advanced NSCLC Patients (Now Available)
08:00 - 08:00 | Presenter: Sangtian Liu
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
- Presentations: 0
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.01-22 - Investigation of Acquired Resistance for EGFR-TKI Plus Bevacizumab as 1st Line Treatment in Patients with EGFR Sensitive Mutant NSCLC
09:45 - 09:45 | Presenter: Yongchang Zhang
- Abstract
Loading... -
+
P1.01-62 - Association of Baseline Pulmonary Fibrosis with the Outcome of PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Shiqi Mao
- Abstract
Loading... -
+
P1.01-121 - Superior Outcomes of 1st Line EGFR TKI in Next-Generation Sequencing Identified Uncommon EGFR Exon 19delins Mutation Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yongchang Zhang
- Abstract
Loading...
-
+
P1.03 - Biology
- Type: Poster Viewing in the Exhibit Hall
- Track: Biology
- Presentations: 0
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.03-50 - Type- and Stage-Specific Genomic Profiles in East Asian Lung Cancer Patients with No TKI-Related Driver Gene Mutations
09:45 - 09:45 | Presenter: Yayi He
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.04-46 - PD-1 Inhibitor Plus Chemotherapy as 2nd/Subsequent Line Setting Demonstrate Superior Efficacy Over PD-1 Inhibitor Alone in Pts of Advanced NSCLC
09:45 - 09:45 | Presenter: Shengxiang Ren
- Abstract
Loading... -
+
P1.04-57 - Metronomic Dosing of Chemotherapy Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Non-Small Cell Lung Cancer (Now Available)
09:45 - 09:45 | Presenter: Yijun Jia
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
- Presentations: 0
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.14-62 - Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Combined Analysis of Two Single-Arm Phase IIIb Studies
09:45 - 09:45 | Author(s): Filippo De Marinis
- Abstract
Loading...
-
+
ES10 - Oncology Drug Approval: Challenges and Opportunities
- Type: Educational Session
- Track: Advanced NSCLC
- Presentations: 6
- Now Available
- Moderators:Caicun Zhou
- Coordinates: 9/08/2019, 13:30 - 15:00, Toronto (1985)
-
+
ES10.01 - US Food and Drug Administration (Now Available)
13:30 - 13:45 | Presenter: Gideon M Blumenthal
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES10.02 - Japan Pharmaceuticals and Medical Devices Agency (Now Available)
13:45 - 14:00 | Presenter: Sumimasa Nagai
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES10.03 - China National Medical Products Administration (Formerly CFDA) (Now Available)
14:00 - 14:15 | Presenter: Tony Mok
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES10.04 - European Medicines Agency (Now Available)
14:15 - 14:30 | Presenter: Jorge Camarero
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES10.05 - Brazilian Health Regulatory Agency - Agência Nacional de Vigilância Sanitária (Now Available)
14:30 - 14:45 | Presenter: Carlos Gil Ferreira
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ES10.06 - Q&A (Now Available)
14:45 - 15:00
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA04 - Models and Biomarkers
- Type: Mini Oral Session
- Track: Biology
- Presentations: 1
- Now Available
- Moderators:Montse Sanchez-Cespedes
- Coordinates: 9/08/2019, 13:30 - 15:00, Interlaken (1988)
-
+
MA04.02 - Molecular Profiling of Adenocarcinoma and Squamous Cell Lung Cancer at Single Cell Resolution (Now Available)
13:35 - 13:40 | Presenter: fengying Wu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA04 - Immuno Combinations and the Role of TMB
- Type: Oral Session
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Moderators:Solange Peters
- Coordinates: 9/08/2019, 15:15 - 16:45, Copenhagen (1980)
-
+
OA04.03 - A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (Now Available)
15:35 - 15:45 | Presenter: Caicun Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Advanced NSCLC
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
- Presentations: 0
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.01-30 - Hepatitis B Infection or Aminotransferase Increase Associate with Poor Outcome of Anti-PD-1 Monotherapy in Patients with Advanced NSCLC
10:15 - 10:15 | Presenter: Yiwei Liu
- Abstract
Loading... -
+
P2.01-79 - Afatinib in EGFR Mutation-Positive (EGFRm+) NSCLC Harbouring Uncommon Mutations: Experience in ‘Real-World’ Clinical Practice
10:15 - 10:15 | Author(s): Wolfgang Brückl
- Abstract
Loading... -
+
P2.01-99 - A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Final Analysis
10:15 - 10:15 | Presenter: Yi-Long Wu
- Abstract
Loading...
